Search
Search Results
##search.searchResults.foundPlural##
-
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
3933PDF: 1492HTML: 9188Untitled: 277Untitled: 183Untitled: 168Untitled: 164Untitled: 180Untitled: 338 -
Anemia in the elderly: not always what it seems.
3308PDF: 1034HTML: 1774Figure 1: 176Figure 1 revised: 179 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4246PDF: 1177HTML: 2154Figure 1: 163 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3053PDF: 875HTML: 7163Kost Fig1: 182Kost Fig 2: 177Kost Fig3: 174Kost Fig 4: 190Kost Fig5: 184Kost fig 6: 173 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2575PDF: 737HTML: 2297 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1416PDF: 901Suppl. Files: 454HTML: 235 -
TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY
3553PDF: 1067HTML: 874 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
2861PDF: 1227HTML: 2698Figure 1: 171 -
AGING WITH THALASSEMIA AND SICKLE CELL DISEASE: A GERONTOLOGICAL MODEL OF ACCELERATED MULTIMORBIDITY AND FUNCTION-CENTERED CARE BEYOND MIDLIFE Thalassemia and Sickle Cell Diseases: Effect of Aging
313PDF: 254Suppl. Files: 44HTML: 11 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2214PDF: 964HTML: 1897 -
Pathologic splenic rupture in a patient with follicular lymphoma
1416PDF: 545HTML: 1189rupture: 178 -
CD56+/CD38+ Neutrophils: Rapid and Specific Flow Cytometric Signature for Chronic Myeloid Leukemia
160PDF: 183Suppl. Files: 33HTML: 16 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2177PDF: 1197HTML: 3709 -
IMPORTANCE OF HYPERBILURUBINEMIA IN DIFFERENTIATION OF PRIMARY AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN PEDIATRIC CASES
1772PDF: 938HTML: 1110Untitled: 152Untitled: 170Untitled: 157Untitled: 158 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3225PDF: 1008HTML: 2024 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4746PDF: 2830HTML: 2278 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
2021PDF: 799HTML: 1045 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3554PDF: 1635HTML: 2674 -
NURSES’ PHYSICAL AND PSYCHOLOGICAL SYMPTOMS DURING THE FIRST COVID-19 LOCKDOWN IN ITALY A nationwide cross-sectional study in stem cell transplantation setting.
1780PDF: 816HTML: 227 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3305PDF: 1962HTML: 7472 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1457PDF: 1058HTML: 216 -
Acquired Hemophilia A successfully treated with rituximab
1935PDF: 1142HTML: 1458Figure 1: 175 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1240PDF: 985HTML: 210







